We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A review on clinical association of serum magnesium and serum fibrinogen levels with acute exacerbation of chronic obstructive pulmonary disease.
- Authors
Niventhi, A.; Praveen, D.; Chowdary, P. Ranadheer; Aanandhi, M. Vijey
- Abstract
Acute exacerbations (AEs) are a leading cause of worsening chronic obstructive pulmonary disease (COPD) in terms of lung function decline, quality of life, and survival. The most important concept of this article is the positive correlation between serum magnesium levels during AE and annual number of COPD-AE episodes. Low serum magnesium is a modifiable risk factor. It is generally believed that due to its bronchodilating effect, a decreased level of magnesium increases COPD exacerbations. Plasma fibrinogen may be an ideal blood biomarker for the existence of systemic inflammation. Those with the high fibrinogen levels had increased admission rates with COPD exacerbations during the follow-up period. This article deals with the association of both serum magnesium and serum fibrinogen levels with AE-COPD.
- Subjects
OBSTRUCTIVE lung diseases; SERUM albumin; FIBRINOGEN; DISEASE exacerbation; CLINICAL trials; MAGNESIUM in the body
- Publication
Drug Invention Today, 2018, Vol 10, Issue 2, p147
- ISSN
0975-7619
- Publication type
Article